βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism

被引：333
|
作者：
Ding, Xunshan [1 ,2 ]
Boney-Montoya, Jamie [2 ]
Owen, Bryn M. [1 ]
Bookout, Angie L. [1 ,3 ]
Coate, Katie Colbert [1 ,4 ]
Mangelsdorf, David J. [1 ,4 ]
Kliewer, Steven A. [1 ,2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
来源：
CELL METABOLISM | 2012年 / 16卷 / 03期
基金：
美国国家卫生研究院;
关键词：
INCREASES ENERGY-EXPENDITURE; ACTIVATED-RECEPTOR-GAMMA; PPAR-ALPHA; INSULIN SENSITIVITY; ADIPOSE-TISSUE; FGF21; MICE; FIBROBLAST-GROWTH-FACTOR-21; EXPRESSION; SYSTEM;
D O I：
10.1016/j.cmet.2012.08.002
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Fibroblast growth factor 21 (FGF21) is a fasting-induced hepatokine that has potent pharmacologic effects in mice, which include improving insulin sensitivity and blunting growth. The single-transmembrane protein beta Klotho functions as a coreceptor for FGF21 in vitro. To determine if beta Klotho is required for FGF21 action in vivo, we generated whole-body and adipose tissue-selective beta Klotho-knockout mice. All of the effects of FGF21 on growth and metabolism were lost in whole-body beta Klotho-knockout mice. Selective elimination of beta Klotho in adipose tissue blocked the acute insulin-sensitizing effects of FGF21. Taken together, these data demonstrate that beta Klotho is essential for FGF21 activity and that beta Klotho in adipose tissue contributes to the beneficial metabolic actions of FGF21.
引用
收藏
页码：387 / 393
页数：7
相关论文
共 50 条
  • [41] Fibroblast growth factor 21 and bone homeostasis
    Tang, Yan
    Zhang, Mei
    BIOMEDICAL JOURNAL, 2023, 46 (04)
  • [42] The role of fibroblast growth factor 21 in atherosclerosis
    Kokkinos, John
    Tang, Shudi
    Rye, Kerry-Anne
    Ong, Kwok Leung
    ATHEROSCLEROSIS, 2017, 257 : 259 - 265
  • [43] Fibroblast growth factor 21 in heart failure
    Tucker, William
    Tucker, Bradley
    Rye, Kerry-Anne
    Ong, Kwok Leung
    HEART FAILURE REVIEWS, 2023, 28 (01) : 261 - 272
  • [44] βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
    Suzuki, Masashi
    Uehara, Yuriko
    Motomura-Matsuzaka, Kaori
    Oki, Junko
    Koyama, Yoshinori
    Kimura, Miho
    Asada, Masahiro
    Komi-Kuramochi, Akiko
    Oka, Syuichi
    Imamura, Toru
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (04) : 1006 - 1014
  • [45] Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
    Michael Freundlich
    Gerardo Gamba
    Bernardo Rodriguez-Iturbe
    Pediatric Nephrology, 2021, 36 : 3007 - 3022
  • [46] Fibroblast growth factor-23 and Klotho in chronic kidney disease
    Vervloet, Marc G.
    Larsson, Tobias E.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2011, 1 (04) : 130 - 135
  • [47] The couple fibroblast growth factor 23 (FGF23)/Klotho
    Prie, Dominique
    ANNALES DE BIOLOGIE CLINIQUE, 2015, 73 (03) : 299 - 304
  • [48] Alpha Klotho and Fibroblast Growth Factor-23 Among Alcoholics
    Quintero-Platt, Geraldine
    Gonzalez-Reimers, Emilio
    Rodriguez-Gaspar, Melchor
    Martin-Gonzalez, Candelaria
    Perez-Hernandez, Onan
    Romero-Acevedo, Lucia
    Espelosin-Ortega, Elisa
    Jose de la Vega-Prieto, Maria
    Santolaria-Fernandez, Francisco
    ALCOHOL AND ALCOHOLISM, 2017, 52 (05): : 542 - 549
  • [49] Fibroblast growth factor 23 and Klotho serum levels in healthy children
    Gkentzi, Despoina
    Efthymiadou, Alexandra
    Kritikou, Dimitra
    Chrysis, Dionisios
    BONE, 2014, 66 : 8 - 14
  • [50] Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease
    Nitta, Kosaku
    Nagano, Nobuo
    Tsuchiya, Ken
    NEPHRON CLINICAL PRACTICE, 2014, 128 (1-2): : 1 - 10
12345